B6;129P2-Rhdtm1Goo/Orl

Status

Available to order

EMMA IDEM:11706
Citation informationRRID:IMSR_EM:11706 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129P2-Rhdtm1Goo/Orl
Alternative nameGOO1
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolRhdtm1Goo
Gene/Transgene symbolRhd

Information from provider

ProviderDominique GOOSSENS
Provider affiliationUMR_S1134-Inserm - Dept de recherches biologiques sur le globule rouge, Institut National de la Transfusion Sanguine-Inserm
Genetic informationRhd (erythroid membrane protein) gene knock-out.
Phenotypic informationHomozygous:
No clinical or cellular abnormalities, complete loss of erythrocyte membrane expression of Rhd, and of Icam4 (with consequent decreased adhesion to endothelial cell line)

Heterozygous:
Normal
Breeding history129P2/OlaHsd x C57BL/6 background.
References
  • Generation and characterisation of Rhd and Rhag null mice.;Goossens Dominique, Trinh-Trang-Tan Marie-Marcelle, Debbia Martine, Ripoche Pierre, Vilela-Lamego Camilo, Louache Fawzia, Vainchenker William, Colin Yves, Cartron Jean-Pierre, ;2010;British journal of haematology;148;161-72; 19807729
  • Generation of mice with inactivated Rh or Rhag genes.;Goossens D, Bony V, Gane P, Colin Y, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;164-6; 16581281
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous 129P2/OlaHsd x C57BL/6 males, wild-type C57BL/6 females
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased exploration in new environment / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • decreased hemoglobin content / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
  • decreased mean corpuscular volume / IMPC
  • decreased circulating cholesterol level / IMPC
  • abnormal skin condition / IMPC
  • decreased circulating free fatty acids level / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • decreased circulating HDL cholesterol level / IMPC
MGI phenotypes (gene matching)
  • decreased mean corpuscular volume / MGI
  • decreased hemoglobin content / MGI
  • abnormal erythrocyte physiology / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • increased circulating iron level / MGI

Literature references

  • Generation and characterisation of Rhd and Rhag null mice.;Goossens Dominique, Trinh-Trang-Tan Marie-Marcelle, Debbia Martine, Ripoche Pierre, Vilela-Lamego Camilo, Louache Fawzia, Vainchenker William, Colin Yves, Cartron Jean-Pierre, ;2010;British journal of haematology;148;161-72; 19807729
  • Generation of mice with inactivated Rh or Rhag genes.;Goossens D, Bony V, Gane P, Colin Y, Cartron J-P, ;2006;Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine;13;164-6; 16581281

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).